Sunday, September 20, 2026
25.8 C
Bengaluru

Philippe Gautron Takes on Role as Senior Vice President & Business Head – APAC at Glenmark Pharmaceuticals

Ho Chi Minh City, Vietnam, March 2026 — Glenmark Pharmaceuticals has named Philippe Gautron as Senior Vice President & Business Head – APAC, entrusting him with leadership of the company’s operations across the Asia-Pacific region. In this role, Gautron will hold full P&L responsibility for 19 markets, supporting Glenmark’s strategy to strengthen its regional presence and drive growth across APAC.

Gautron joins Glenmark with extensive global leadership experience in the pharmaceutical sector and a strong track record in business transformation, market expansion, and strategic partnerships.

Prior to this appointment, he served as General Manager at STADA Pymepharco, where he was responsible for overall P&L and legal oversight. His role included managing commercial operations, manufacturing facilities, and multiple legal entities. During his tenure, he led significant transformation initiatives, including leadership restructuring, redesigning the go-to-market strategy across retail and medical channels, and strengthening government affairs and compliance frameworks.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Topics

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...
spot_img

Related Articles

spot_imgspot_img